Kohjin Bio Co., Ltd. (TYO:177A)
Japan flag Japan · Delayed Price · Currency is JPY
1,202.00
-18.00 (-1.48%)
At close: Feb 6, 2026

Kohjin Bio Company Description

Kohjin Bio Co., Ltd. manufactures and sells of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.

The company offers tissue culture mediums for human cell culture, including human lymphocyte culture, hepatoblastoma-derived cell lines, adipose- derived stem cells, neural stem cells, fibroblast, vascular endothelial cells, and epidermal keratinocyte human cell cultures.

It also provides industrial cell cultures for CHO, hybridomas, and insect cells; exosome production; cryopreservation solutions; cell dissociation agents; adoptCell-NK kits, and bag and other materials.

In addition, the company offers microbial mediums for clinical microbiology culture mediums, microbiology culture medium for food and environment, antimicrobial resistance test kits, and staining kits for microbiology; immunochromatographic assay kit; I-block series; and human blood, serum, and plasma.

Further, it engages in the production and sale of laboratory animal, sale of medical equipment, trust of animal immunization and antibody preparation, and import and export of products and raw materials.

The company was formerly known as Kohjin Co.,Ltd and changed its name to Kohjin Bio Co., Ltd. in 1989.

Kohjin Bio Co., Ltd. was incorporated in 1981 and is headquartered in Sakado, Japan.

Kohjin Bio Co., Ltd.
CountryJapan
Founded1981
IndustryBiotechnology
SectorHealthcare
Employees167
CEOTakahito Nakamura

Contact Details

Address:
5-1-3
Sakado, 350-0214
Japan
Phone81 49 284 3781
Websitekohjin-bio.jp

Stock Details

Ticker Symbol177A
ExchangeTokyo Stock Exchange
Stock TypeCommon Stock
Fiscal YearApril - March
Reporting CurrencyJPY
ISIN NumberJP3283630006
SIC Code2836

Key Executives

NamePosition
Takahito NakamuraChief Executive Officer